FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093293313> ?p ?o ?g. }

• W2093293313 endingPage "e49004" @default.
• W2093293313 startingPage "e49004" @default.
• W2093293313 abstract "Currently, statins are the only drugs acting on the mammalian isoprenoid pathway. The mammalian genes in this pathway are not easily amenable to genetic manipulation. Thus, it is difficult to study the effects of the inhibition of various enzymes on the intermediate and final products in the isoprenoid pathway. In fission yeast, antifungal compounds such as azoles and terbinafine are available as inhibitors of the pathway in addition to statins, and various isoprenoid pathway mutants are also available. Here in these mutants, treated with statins or antifungals, we quantified the final and intermediate products of the fission yeast isoprenoid pathway using liquid chromatography-mass spectrometry/mass spectrometry. In hmg1-1, a mutant of the gene encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR), ergosterol (a final sterol product), and squalene (an intermediate pathway product), were decreased to approximately 80% and 10%, respectively, compared with that of wild-type cells. Consistently in wild-type cells, pravastatin, an HMGR inhibitor decreased ergosterol and squalene, and the effect was more pronounced on squalene. In hmg1-1 mutant and in wild-type cells treated with pravastatin, the decrease in the levels of farnesyl pyrophosphate and geranylgeranyl pyrophosphate respectively was larger than that of ergosterol but was smaller than that of squalene. In Δerg6 or Δsts1 cells, mutants of the genes involved in the last step of the pathway, ergosterol was not detected, and the changes of intermediate product levels were distinct from that of hmg1-1 mutant. Notably, in wild-type cells miconazole and terbinafine only slightly decreased ergosterol level. Altogether, these studies suggest that the pleiotropic phenotypes caused by the hmg1-1 mutation and pravastatin might be due to decreased levels of isoprenoid pyrophosphates or other isoprenoid pathway intermediate products rather than due to a decreased ergosterol level." @default.
• W2093293313 created "2016-06-24" @default.
• W2093293313 creator A5006204041 @default.
• W2093293313 creator A5026511440 @default.
• W2093293313 creator A5053143384 @default.
• W2093293313 creator A5054625101 @default.
• W2093293313 creator A5058336972 @default.
• W2093293313 creator A5069884202 @default.
• W2093293313 date "2012-11-07" @default.
• W2093293313 modified "2023-09-26" @default.
• W2093293313 title "A Genetic and Pharmacological Analysis of Isoprenoid Pathway by LC-MS/MS in Fission Yeast" @default.
• W2093293313 cites W1489120006 @default.
• W2093293313 cites W1887180409 @default.
• W2093293313 cites W1971805633 @default.
• W2093293313 cites W1996532697 @default.
• W2093293313 cites W2005458058 @default.
• W2093293313 cites W2027484665 @default.
• W2093293313 cites W2028157741 @default.
• W2093293313 cites W2028583333 @default.
• W2093293313 cites W2028967650 @default.
• W2093293313 cites W2030821434 @default.
• W2093293313 cites W2032471797 @default.
• W2093293313 cites W2037736620 @default.
• W2093293313 cites W2041486445 @default.
• W2093293313 cites W2050354560 @default.
• W2093293313 cites W2071124826 @default.
• W2093293313 cites W2071613600 @default.
• W2093293313 cites W2104657811 @default.
• W2093293313 cites W2105126237 @default.
• W2093293313 cites W2107575026 @default.
• W2093293313 cites W2112866008 @default.
• W2093293313 cites W2114210981 @default.
• W2093293313 cites W2122646330 @default.
• W2093293313 cites W2194986544 @default.
• W2093293313 cites W4235797558 @default.
• W2093293313 cites W4293247451 @default.
• W2093293313 doi "https://doi.org/10.1371/journal.pone.0049004" @default.
• W2093293313 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3492200" @default.
• W2093293313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23145048" @default.
• W2093293313 hasPublicationYear "2012" @default.
• W2093293313 type Work @default.
• W2093293313 sameAs 2093293313 @default.
• W2093293313 citedByCount "10" @default.
• W2093293313 countsByYear W20932933132013 @default.
• W2093293313 countsByYear W20932933132016 @default.
• W2093293313 countsByYear W20932933132017 @default.
• W2093293313 countsByYear W20932933132019 @default.
• W2093293313 countsByYear W20932933132020 @default.
• W2093293313 countsByYear W20932933132021 @default.
• W2093293313 countsByYear W20932933132022 @default.
• W2093293313 countsByYear W20932933132023 @default.
• W2093293313 crossrefType "journal-article" @default.
• W2093293313 hasAuthorship W2093293313A5006204041 @default.
• W2093293313 hasAuthorship W2093293313A5026511440 @default.
• W2093293313 hasAuthorship W2093293313A5053143384 @default.
• W2093293313 hasAuthorship W2093293313A5054625101 @default.
• W2093293313 hasAuthorship W2093293313A5058336972 @default.
• W2093293313 hasAuthorship W2093293313A5069884202 @default.
• W2093293313 hasBestOaLocation W20932933131 @default.
• W2093293313 hasConcept C104317684 @default.
• W2093293313 hasConcept C112243037 @default.
• W2093293313 hasConcept C134651460 @default.
• W2093293313 hasConcept C143065580 @default.
• W2093293313 hasConcept C181199279 @default.
• W2093293313 hasConcept C185592680 @default.
• W2093293313 hasConcept C206103511 @default.
• W2093293313 hasConcept C207583985 @default.
• W2093293313 hasConcept C2776703722 @default.
• W2093293313 hasConcept C2776990775 @default.
• W2093293313 hasConcept C2777910421 @default.
• W2093293313 hasConcept C2778163477 @default.
• W2093293313 hasConcept C2778718757 @default.
• W2093293313 hasConcept C2779222958 @default.
• W2093293313 hasConcept C2779247237 @default.
• W2093293313 hasConcept C2779969316 @default.
• W2093293313 hasConcept C2779982574 @default.
• W2093293313 hasConcept C553450214 @default.
• W2093293313 hasConcept C55493867 @default.
• W2093293313 hasConcept C85411794 @default.
• W2093293313 hasConcept C86803240 @default.
• W2093293313 hasConceptScore W2093293313C104317684 @default.
• W2093293313 hasConceptScore W2093293313C112243037 @default.
• W2093293313 hasConceptScore W2093293313C134651460 @default.
• W2093293313 hasConceptScore W2093293313C143065580 @default.
• W2093293313 hasConceptScore W2093293313C181199279 @default.
• W2093293313 hasConceptScore W2093293313C185592680 @default.
• W2093293313 hasConceptScore W2093293313C206103511 @default.
• W2093293313 hasConceptScore W2093293313C207583985 @default.
• W2093293313 hasConceptScore W2093293313C2776703722 @default.
• W2093293313 hasConceptScore W2093293313C2776990775 @default.
• W2093293313 hasConceptScore W2093293313C2777910421 @default.
• W2093293313 hasConceptScore W2093293313C2778163477 @default.
• W2093293313 hasConceptScore W2093293313C2778718757 @default.
• W2093293313 hasConceptScore W2093293313C2779222958 @default.
• W2093293313 hasConceptScore W2093293313C2779247237 @default.
• W2093293313 hasConceptScore W2093293313C2779969316 @default.
• W2093293313 hasConceptScore W2093293313C2779982574 @default.
• W2093293313 hasConceptScore W2093293313C553450214 @default.

• next